Cytosolic and nuclear androgen receptor activity in the cancer of the larynx
Abstract
It is well known that the larynx is a target organ for androgens and the cancer of larynx is more frequent in male subjects. We have evaluated the androgen receptors (AR) in the cytosol (ACR) and in salt extractable (ANR) and salt resistant nuclear fraction (AMR) in a group of 24 male patients with cancer of the larynx surgically removed. In addition specimens obtained from the normal mucosa of the same subjects were analyzed. In 5 patients estrogen (ER) and progesterone (PgR) receptors were also assayed. In all subjects blood samples were taken before surgery for the assay of the following hormones: LH, FSH, estradiol, testosterone, dihydrotestosterone, Δ 4-androstenedione, dehydroepiandrosterone sulfate, Cortisol. The results observed showed that 18 out of 24 normal larynx mucosa specimens and 17 out of 24 larynx cancer specimens were positive for ACR or ANR or AMR. The 5 samples of normal and cancer tissues analyzed for ER and PgR were negative. In conclusion there is no significant correlation between AR positivity from one size, histology, degree of differentiation and invasivity of the cancer, age of patients and hormonal blood levels from the other. The high ANR and AMR positivity (normal hormonal translocation and binding on DNA acceptors) confirm that the normal and cancer larynx are target tissue for androgens and establish the hormone dependence of this cancer. Hormonal therapy could be envisaged as an alternative or a complementary therapy for this type of cancer at least in the cases in which the analysis of hormone receptors will prove to be positive.
Key-words
Cytosolic and nuclear androgen receptors cancer larynxPreview
Unable to display preview. Download preview PDF.
References
- 1.Reiner Z., Patric V., Curtila D. Cytoplasmic androgen receptor content in cancer of the larynx. 7th Inthernational Congress of Endocrinology. Quebec 1984. Excerpta Medica, p. 1337, (Abstract).Google Scholar
- 2.Saez S., Sakai F. Androgen receptors in human pharyngolaryngeal mucosa and pharyngo-laryngeal epithelioma. J. Steroid Biochem. 7: 919, 1976.PubMedCrossRefGoogle Scholar
- 3.Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193: 265, 1951.PubMedGoogle Scholar
- 4.Burton K. Determination of the DNA concentration with diphenylamine. In: Grossman L., Moldave K. (Eds.), Methods in Enzymology. Academic Press, New York, 1968, vol. XII, p. 163.Google Scholar
- 5.Barrack E.R., Bujnovszky P., Walsh P.C. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues. Characterization of nuclear salt-resistant receptors. Cancer Res. 43: 1107, 1983.PubMedGoogle Scholar
- 6.EORTC: Breast Cancer Cooperative Group. Standards for assessment of estrogen receptors in human breast cancers. Eur. J. Cancer 9: 379, 1973.CrossRefGoogle Scholar
- 7.EORTC: Breast Cancer Cooperative Group. Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second EORTC workshop, held on 16–17 March 1979, in the Netherland’s Cancer Institute. Eur. J. Cancer 16: 1513, 1980.CrossRefGoogle Scholar
- 8.Rosai J. Ackerman’s Surgical Pathology, ed. 6. Mosby Company Ed., St. Louis, 1981, p. 219.Google Scholar
- 9.Matsumoto K., Takeyasu K., Mizutani S., Hamanaka Y., Vozumi T. Plasma testosterone levels following surgical stress in male patients. Acta Endocrinol. (Kbh.) 65: 11, 1970.Google Scholar